Suppr超能文献

环状 RNA 在肺动脉高压中的作用。

The role of circular RNAs in pulmonary hypertension.

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.

Vera Moulton Wall Center for Pulmonary Vascular Disease, Stanford University, Stanford, CA, USA.

出版信息

Eur Respir J. 2022 Dec 1;60(6). doi: 10.1183/13993003.00012-2022. Print 2022 Dec.

Abstract

Circular RNAs (circRNAs) are endogenous, covalently circularised, non-protein-coding RNAs generated from back-splicing. Most circRNAs are very stable, highly conserved, and expressed in a tissue-, cell- and developmental stage-specific manner. circRNAs play a significant role in various biological processes, such as regulation of gene expression and protein translation sponging of microRNAs and binding with RNA-binding proteins. circRNAs have become a topic of great interest in research due to their close link with the development of various diseases. Their high stability, conservation and abundance in body fluids make them promising biomarkers for many diseases. A growing body of evidence suggests that aberrant expression of circRNAs and their targets plays a crucial role in pulmonary vascular remodelling and pulmonary arterial hypertension (group 1) as well as other forms (groups 3 and 4) of pulmonary hypertension (PH). Here we discuss the roles and molecular mechanisms of circRNAs in the pathogenesis of pulmonary vascular remodelling and PH. We also highlight the therapeutic and biomarker potential of circRNAs in PH.

摘要

环状 RNA(circRNAs)是一类内源性、共价闭环、无蛋白质编码的 RNA,由反向剪接产生。大多数 circRNAs 非常稳定、高度保守,并表现出组织、细胞和发育阶段特异性表达。circRNAs 在各种生物学过程中发挥着重要作用,如基因表达和蛋白质翻译的调控、miRNA 的海绵作用以及与 RNA 结合蛋白的结合。由于它们与各种疾病的发展密切相关,circRNAs 成为研究的热点。它们在体液中的高稳定性、保守性和丰度使它们成为许多疾病有前途的生物标志物。越来越多的证据表明,circRNAs 及其靶标的异常表达在肺血管重塑和肺动脉高压(第 1 组)以及其他形式(第 3 组和第 4 组)的肺动脉高压(PH)中起着关键作用。在这里,我们讨论了 circRNAs 在肺血管重塑和 PH 发病机制中的作用和分子机制。我们还强调了 circRNAs 在 PH 中的治疗和生物标志物潜力。

相似文献

1
The role of circular RNAs in pulmonary hypertension.
Eur Respir J. 2022 Dec 1;60(6). doi: 10.1183/13993003.00012-2022. Print 2022 Dec.
2
Circular RNAs Regulate Vascular Remodelling in Pulmonary Hypertension.
Dis Markers. 2022 Nov 3;2022:4433627. doi: 10.1155/2022/4433627. eCollection 2022.
3
Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers.
Pharmacol Ther. 2021 Apr;220:107715. doi: 10.1016/j.pharmthera.2020.107715. Epub 2020 Oct 24.
4
Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism.
Animal Model Exp Med. 2022 Feb;5(1):38-47. doi: 10.1002/ame2.12208. Epub 2022 Jan 27.
6
The Landscape of Noncoding RNA in Pulmonary Hypertension.
Biomolecules. 2022 Jun 7;12(6):796. doi: 10.3390/biom12060796.
8
Circular RNAs: Promising Biomarkers for Human Diseases.
EBioMedicine. 2018 Aug;34:267-274. doi: 10.1016/j.ebiom.2018.07.036. Epub 2018 Aug 2.
9
Emergent Roles of Circular RNAs in Metabolism and Metabolic Disorders.
Int J Mol Sci. 2022 Jan 18;23(3):1032. doi: 10.3390/ijms23031032.
10
Role of Circular RNAs in Pulmonary Fibrosis.
Int J Mol Sci. 2022 Sep 10;23(18):10493. doi: 10.3390/ijms231810493.

引用本文的文献

1
Circular RNAs as Biomarkers in the Diagnosis of Human Diseases.
Adv Exp Med Biol. 2025;1485:211-226. doi: 10.1007/978-981-96-9428-0_14.
3
Comprehensive evaluation of non-coding RNA-mediated autophagy regulation in myocardial ischemia-reperfusion injury.
Front Pharmacol. 2025 Apr 25;16:1581341. doi: 10.3389/fphar.2025.1581341. eCollection 2025.
5
Superenhancer-driven circRNA Myst4 involves in pulmonary artery smooth muscle cell ferroptosis in pulmonary hypertension.
iScience. 2024 Sep 12;27(10):110900. doi: 10.1016/j.isci.2024.110900. eCollection 2024 Oct 18.
7
Plasma Biomarkers for Hypertension-Mediated Organ Damage Detection: A Narrative Review.
Biomedicines. 2024 May 12;12(5):1071. doi: 10.3390/biomedicines12051071.
8
CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension.
J Am Heart Assoc. 2024 Mar 19;13(6):e031867. doi: 10.1161/JAHA.123.031867. Epub 2024 Mar 18.
9
Circular RNAs: emerging players in asthma and COPD.
Front Cell Dev Biol. 2023 Nov 24;11:1267792. doi: 10.3389/fcell.2023.1267792. eCollection 2023.

本文引用的文献

1
CircFISH: A Novel Method for the Simultaneous Imaging of Linear and Circular RNAs.
Cancers (Basel). 2022 Jan 15;14(2):428. doi: 10.3390/cancers14020428.
4
A Neuroligin Isoform Translated by circNlgn Contributes to Cardiac Remodeling.
Circ Res. 2021 Aug 20;129(5):568-582. doi: 10.1161/CIRCRESAHA.120.318364. Epub 2021 Jul 15.
5
Promising therapeutic approaches in pulmonary arterial hypertension.
Curr Opin Pharmacol. 2021 Aug;59:127-139. doi: 10.1016/j.coph.2021.05.003. Epub 2021 Jun 30.
6
Noncoding RNA therapeutics - challenges and potential solutions.
Nat Rev Drug Discov. 2021 Aug;20(8):629-651. doi: 10.1038/s41573-021-00219-z. Epub 2021 Jun 18.
8
CircRNAs: role in human diseases and potential use as biomarkers.
Cell Death Dis. 2021 May 11;12(5):468. doi: 10.1038/s41419-021-03743-3.
9
Improving Right Ventricular Function by Increasing BMP Signaling with FK506.
Am J Respir Cell Mol Biol. 2021 Sep;65(3):272-287. doi: 10.1165/rcmb.2020-0528OC.
10
Circular RNA-HIPK3 regulates human pulmonary artery endothelial cells function and vessel growth by regulating microRNA-328-3p/STAT3 axis.
Pulm Circ. 2021 Mar 29;11(2):20458940211000234. doi: 10.1177/20458940211000234. eCollection 2021 Apr-Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验